Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
UBS
QuintilesIMS
Federal Trade Commission
Accenture
Harvard Business School

Generated: September 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,445,524

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,445,524 protect, and when does it expire?

Patent 8,445,524 protects TREANDA and is included in one NDA.

Protection for TREANDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has sixteen patent family members in ten countries.

Summary for Patent: 8,445,524
Title:Solid forms of bendamustine hydrochloride
Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
Inventor(s): Courvoisier; Laurent D. (Thorndale, PA), McKean; Robert E. (Chester Springs, PA), Jansch; Hans-Joachim (Radebeul, DE)
Assignee: Cephalon, Inc. (Frazer, PA)
Application Number:13/301,979
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,445,524
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Formulation; Process;

Drugs Protected by US Patent 8,445,524

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Cephalon TREANDA bendamustine hydrochloride POWDER;IV (INFUSION) 022249-002 May 1, 2009 RX Yes Yes   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Cephalon TREANDA bendamustine hydrochloride POWDER;IV (INFUSION) 022249-001 Mar 20, 2008 RX Yes Yes   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Cephalon TREANDA bendamustine hydrochloride SOLUTION;IV (INFUSION) 022249-003 Sep 13, 2013 DISCN Yes No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
Cephalon TREANDA bendamustine hydrochloride SOLUTION;IV (INFUSION) 022249-004 Sep 13, 2013 DISCN Yes No   Try a Free Trial   Try a Free Trial Y   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,445,524

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 072777   Try a Free Trial
Canada 2718939   Try a Free Trial
China 101980698   Try a Free Trial
China 103550159   Try a Free Trial
China 105693620   Try a Free Trial
European Patent Office 2271315   Try a Free Trial
European Patent Office 3150197   Try a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
McKesson
Merck
Cipla
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.